SWFT Clinical Services Ltd. is a wholly owned subsidiary of South Warwickshire NHS Foundation Trust.
When South Warwickshire Trust was awarded Foundation Trust status in 2010, it was one of the first in the country to set up a limited company as a subsidiary. Since then, many other Foundation Trusts have set up similar Pharmacy businesses, and the model is now well established. The company commenced operating in March 2011. The company operates the outpatient pharmacy for the Trust based at Warwick Hospital, a private patient day surgery clinic in Stratford-upon-Avon (www.thestratfordclinic.co.uk) and The Beauchamp Suite at Warwick Hospital offering NHS patients the choice to pay for a private en-suite room in a quieter part of the hospital.
The company’s primary purpose is to develop income for the Trust through commercial activities. All profits made by the company’s trading activities are either reinvested in the business or returned to the Trust for reinvestment in health care services.
Social Impact Declaration: Social-Impact-Declaration_SWFT-Clinical-Services.pdf
Social Impact Statements:
Social Impact Statements
The Social Enterprise Mark criteria includes a requirement that the applicant can demonstrate that social and/or environmental objectives are being achieved.
In support of this, new applicants and renewing Mark holders must submit Social Impact Statements that summarise their headline activities and achievements, helping show how they are striving to make a difference and stand up to scrutiny of purpose as a social enterprise.
1) Key activities to support patients in local community
In this current year we have expanded our outpatient pharmacy services to a second site, growing our reach into the community to serve local populations. Notably we have initiated a couple of projects with the elderly which go beyond the reach of a traditional pharmacy; firstly we have invested in a shoe fitting service for the elderly which is aimed at falls prevention. We open our consulting room to podiatrists who are available every week to see patients and have invested in a specialist range of shoes which fit "difficult feet". These shoes are also designed for patients with diabetes; with the right foot ware, hospital admissions can be avoided.
The second project we invested in was a joint project with a local GP surgery, whereby we identified elderly patients at risk of hospital admission due to poly-pharmacy. We sent our specially trained pharmacists into these patients homes to meet with the family as well as the patient and assess their ability to comply with their prescription. This work has been shortlisted for a Health Service Journal award due to its impact on preventing admissions and reduction in medicines waste.
In addition to our pharmacy work we have invested in a project with Warwick University, who have developed a genetic test that has the potential to identify women at risk of developing post natal depression. We are currently recruiting 1,000 women into a clinical study to determine if such a test can be developed. One in four women develop anxiety and depression during pregnancy and early data soon to be published from our study shows this leads to low birth weight babies; the impact of this are health complications in both mum and baby which can effect the entire family.
2) Key measures of support provided
The outpatient pharmacy is there to provide a service to some 300,000 patients that utilise outpatient or A&E services at the hospital. The pharmacy operates a shop and the profits from this (some £100,000) were gift aided to a local affiliated health charity earlier this year. This charity supports local hospitals by purchasing medical equipment and distributing Christmas gifts for patients that find themselves in hospital over the festive period.
The elderly pharmacy project was a community based initiative, which, extrapolated from one GP Practice to the local area, encompasses some 175,000 elderly patients in the community. The project investment cost was £45,000, which the Company funded.
The post natal depression project could extend to all 730,000 women that give birth every year, but is currently confined to the maternity unit within Warwick hospital which deals with 3,000 live births per annum. The investment cost was £60,000 over two years.
In total the Company has distributed around £200,000 in support of social purposes.
3) Benefits for local communities
The community project with the frail elderly in collaboration with a local GP Practice, identified 70 at risk patients who were taking more than 8 medications per day. These patients were visited in their homes by a specialist pharmacist.
More than £7,000 of unwanted medicines were removed from these patients homes, one in three patients had their medicines regimen adjusted, many of whom were able to tail off an opiate medicine for pain relief to paracetamol, thereby reducing the risk of drowsiness, constipation and falls.
The project identified that the risk factor for A&E admission in this group of patients was reduced by 66%. This work is being published and shared with CCGs across the country. It is also planned to roll this out across to some other 35 GP practices in the locality.